FDA Inspection 1143607 — IDT Biologika GmbH

IDT Biologika GmbH — FEI 3005001757

The FDA completed an inspection of IDT Biologika GmbH on September 10, 2020 in Dessau-Rosslau. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 10, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dessau-Rosslau (Germany)

Additional Details

Mutual Recognition Agreement (MRA)